Literature DB >> 2536145

Evaluation of severe growth retardation using cordocentesis--hematologic and metabolic alterations by etiology.

C P Weiner1, R A Williamson.   

Abstract

Hematologic and respiratory blood gas parameters were studied in 21 fetuses with severe or early-onset (at or before 34 weeks) growth retardation and in 44 age-matched control fetuses. Diagnostic categories included uteroplacental insufficiency (N = 7) and uteroplacental insufficiency with associated fetal structural abnormality (N = 7), aneuploidy (N = 5), and congenital infection (N = 2). The mean (+/- 1 SEM) gestational age was 29.3 +/- 1 week. Compared with the control group matched for gestational age, the growth-retarded fetuses had higher hematocrits regardless of etiology. The platelet count was reduced in growth-retarded fetuses with aneuploidy (P less than .05). Leukopenia was observed in a fetus with congenital infection and in the group of fetuses with uteroplacental insufficiency unassociated with a structural abnormality (P less than .05). Leukocytosis was seen in growth-retarded aneuploid fetuses (P less than .01). The pH, pO2, and percent oxygen saturation were each lower in growth-retarded fetuses with either uteroplacental insufficiency or aneuploidy, and the pCO2 and bicarbonate were higher compared with controls (each P less than or equal to .05). Appropriately grown aneuploid fetuses had normal hematologic and respiratory blood gas measurements but were significantly more likely not to be trisomic (P = .04). Fetuses with uteroplacental insufficiency unassociated with a structural anomaly had significantly higher umbilical artery systolic/diastolic ratios than both the control group (P = .0002) and the group with uteroplacental insufficiency and a structural anomaly (P less than .008). This investigation confirms previous studies of fetuses suffering uteroplacental insufficiency and extends the observations to other etiologies.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2536145

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

1.  Effects of maternal hypertension on the neonatal haemogram in southern Nigeria: A case-control study.

Authors:  Helen C Okoye; Lisa I Eweputanna; Kaladada I Korubo; Oseikhuemen A Ejele
Journal:  Malawi Med J       Date:  2016-12       Impact factor: 0.875

2.  MRI quantification of human fetal O2 delivery rate in the second and third trimesters of pregnancy.

Authors:  Ana E Rodríguez-Soto; Michael C Langham; Osheiza Abdulmalik; Erin K Englund; Nadav Schwartz; Felix W Wehrli
Journal:  Magn Reson Med       Date:  2018-01-22       Impact factor: 4.668

Review 3.  Disorders of the fetomaternal unit: hematologic manifestations in the fetus and neonate.

Authors:  L Vandy Black; Akhil Maheshwari
Journal:  Semin Perinatol       Date:  2009-02       Impact factor: 3.300

Review 4.  Maternal preeclampsia and neonatal outcomes.

Authors:  Carl H Backes; Kara Markham; Pamela Moorehead; Leandro Cordero; Craig A Nankervis; Peter J Giannone
Journal:  J Pregnancy       Date:  2011-04-04

5.  Neonatal Thrombocytopenia as a Consequence of Maternal Preeclampsia.

Authors:  Ram R Kalagiri; Saiara Choudhury; Timothy Carder; Vinayak Govande; Madhava R Beeram; M Nasir Uddin
Journal:  AJP Rep       Date:  2015-10-28

6.  Metabolic profiling and targeted lipidomics reveals a disturbed lipid profile in mothers and fetuses with intrauterine growth restriction.

Authors:  Jezid Miranda; Rui V Simões; Cristina Paules; Daniel Cañueto; Miguel A Pardo-Cea; María L García-Martín; Francesca Crovetto; Rocio Fuertes-Martin; Monica Domenech; María D Gómez-Roig; Elisenda Eixarch; Ramon Estruch; Stefan R Hansson; Nuria Amigó; Nicolau Cañellas; Fatima Crispi; Eduard Gratacós
Journal:  Sci Rep       Date:  2018-09-11       Impact factor: 4.379

7.  Perinatal factors affecting platelet parameters in late preterm and term neonates.

Authors:  Hayato Go; Hitoshi Ohto; Kenneth E Nollet; Nozomi Kashiwabara; Mina Chishiki; Masato Hoshino; Kei Ogasawara; Yukihiko Kawasaki; Nobuo Momoi; Mitsuaki Hosoya
Journal:  PLoS One       Date:  2020-11-19       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.